tiprankstipranks
Trending News
More News >
QuiaPEG Pharmaceuticals Holding AB (SE:QUIA)
:QUIA
Advertisement

QuiaPEG Pharmaceuticals Holding AB (QUIA) Price & Analysis

Compare
0 Followers

QUIA Stock Chart & Stats


Financials

QUIA FAQ

What was QuiaPEG Pharmaceuticals Holding AB’s price range in the past 12 months?
QuiaPEG Pharmaceuticals Holding AB lowest stock price was <kr0.01 and its highest was kr0.06 in the past 12 months.
    What is QuiaPEG Pharmaceuticals Holding AB’s market cap?
    QuiaPEG Pharmaceuticals Holding AB’s market cap is kr7.43M.
      When is QuiaPEG Pharmaceuticals Holding AB’s upcoming earnings report date?
      QuiaPEG Pharmaceuticals Holding AB’s upcoming earnings report date is Aug 28, 2025 which is in 32 days.
        How were QuiaPEG Pharmaceuticals Holding AB’s earnings last quarter?
        QuiaPEG Pharmaceuticals Holding AB released its earnings results on Mar 03, 2025. The company reported -kr0.012 earnings per share for the quarter, missing the consensus estimate of N/A by -kr0.012.
          Is QuiaPEG Pharmaceuticals Holding AB overvalued?
          According to Wall Street analysts QuiaPEG Pharmaceuticals Holding AB’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
            Does QuiaPEG Pharmaceuticals Holding AB pay dividends?
            QuiaPEG Pharmaceuticals Holding AB pays a Annually dividend of kr239.146 which represents an annual dividend yield of N/A. See more information on QuiaPEG Pharmaceuticals Holding AB dividends here
              What is QuiaPEG Pharmaceuticals Holding AB’s EPS estimate?
              QuiaPEG Pharmaceuticals Holding AB’s EPS estimate for its next earnings report is not yet available.
              How many shares outstanding does QuiaPEG Pharmaceuticals Holding AB have?
              QuiaPEG Pharmaceuticals Holding AB has 2,124,285,000 shares outstanding.
                What happened to QuiaPEG Pharmaceuticals Holding AB’s price movement after its last earnings report?
                QuiaPEG Pharmaceuticals Holding AB reported an EPS of -kr0.012 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -10.345%.
                  Which hedge fund is a major shareholder of QuiaPEG Pharmaceuticals Holding AB?
                  Currently, no hedge funds are holding shares in SE:QUIA

                  Company Description

                  QuiaPEG Pharmaceuticals Holding AB

                  QuiaPEG Pharmaceuticals Holding AB (publ), a biotech company, develops biopharmaceutical products for the treatment of metabolic disorders. It develops biopharmaceuticals based on PEGylation technology platform, which is applicable on proteins, peptides, and small molecules or oligonucleotides. The company has strategic collaboration with Cobra Biologics AB for the refinement of biopharmaceutical products. The company was formerly known as Oligovation AB and changed its name to QuiaPEG Pharmaceuticals Holding AB (publ). QuiaPEG Pharmaceuticals Holding AB (publ) was founded in 2012 and is headquartered in Solna, Sweden.
                  Similar Stocks
                  Company
                  Price & Change
                  Follow
                  CombiGene AB
                  ExpreS2ion Biotech Holding AB
                  Scandion Oncology A/S
                  Popular Stocks
                  What am I Missing?
                  Make informed decisions based on Top Analysts' activity
                  Know what industry insiders are buying
                  Get actionable alerts from top Wall Street Analysts
                  Find out before anyone else which stock is going to shoot up
                  Get powerful stock screeners & detailed portfolio analysis